283 related articles for article (PubMed ID: 25985952)
1. Recent advances in polymer drug conjugates.
Sharma R; Singla N; Mehta S; Gaba T; Rawal RK; Rao HS; Bhardwaj TR
Mini Rev Med Chem; 2015; 15(9):751-61. PubMed ID: 25985952
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and ex-vivo release studies of colon-specific polyphosphazene-anticancer drug conjugates.
Sharma R; Rawal RK; Malhotra M; Sharma AK; Bhardwaj TR
Bioorg Med Chem; 2014 Feb; 22(3):1104-14. PubMed ID: 24405812
[TBL] [Abstract][Full Text] [Related]
3. Recent research progress on polyphosphazene-based drug delivery systems.
Ni Z; Yu H; Wang L; Shen D; Elshaarani T; Fahad S; Khan A; Haq F; Teng L
J Mater Chem B; 2020 Feb; 8(8):1555-1575. PubMed ID: 32025683
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and properties of a new micellar polyphosphazene-platinum(II) conjugate drug.
Avaji PG; Joo HI; Park JH; Park KS; Jun YJ; Lee HJ; Sohn YS
J Inorg Biochem; 2014 Nov; 140():45-52. PubMed ID: 25061690
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Studies on Novel Polymeric Prodrugs of Erlotinib for Colon Drug Delivery.
Kumar S; Sharma B; Bhardwaj TR; Singh RK
Anticancer Agents Med Chem; 2021; 21(3):383-392. PubMed ID: 32781967
[TBL] [Abstract][Full Text] [Related]
6. Designing polymer conjugates as lysosomotropic nanomedicines.
Duncan R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
[TBL] [Abstract][Full Text] [Related]
7. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.
Nicolas J; Mura S; Brambilla D; Mackiewicz N; Couvreur P
Chem Soc Rev; 2013 Feb; 42(3):1147-235. PubMed ID: 23238558
[TBL] [Abstract][Full Text] [Related]
8. Polymer platforms for drug delivery and biomedical imaging.
Lu ZR; Ye F; Vaidya A
J Control Release; 2007 Oct; 122(3):269-77. PubMed ID: 17662500
[TBL] [Abstract][Full Text] [Related]
9. Polymer conjugates: nanosized medicines for treating cancer.
Vicent MJ; Duncan R
Trends Biotechnol; 2006 Jan; 24(1):39-47. PubMed ID: 16307811
[TBL] [Abstract][Full Text] [Related]
10. HPMA-based polymeric conjugates in anticancer therapeutics.
Rani S; Gupta U
Drug Discov Today; 2020 Jun; 25(6):997-1012. PubMed ID: 32334073
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a novel biodegradable and electroactive polyphosphazene for biomedical application.
Zhang QS; Yan YH; Li SP; Feng T
Biomed Mater; 2009 Jun; 4(3):035008. PubMed ID: 19468157
[TBL] [Abstract][Full Text] [Related]
12. Effect of side group chemistry on the properties of biodegradable L-alanine cosubstituted polyphosphazenes.
Singh A; Krogman NR; Sethuraman S; Nair LS; Sturgeon JL; Brown PW; Laurencin CT; Allcock HR
Biomacromolecules; 2006 Mar; 7(3):914-8. PubMed ID: 16529431
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents.
Taghipour-Sabzevar V; Sharifi T; Moghaddam MM
Ther Deliv; 2019 Aug; 10(8):527-550. PubMed ID: 31496433
[TBL] [Abstract][Full Text] [Related]
14. Hyperbranched polyphosphates: synthesis, functionalization and biomedical applications.
Liu J; Huang W; Pang Y; Yan D
Chem Soc Rev; 2015 Jun; 44(12):3942-53. PubMed ID: 26008957
[TBL] [Abstract][Full Text] [Related]
15. Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.
Jun YJ; Park JH; Avaji PG; Park KS; Lee KE; Lee HJ; Sohn YS
Int J Nanomedicine; 2017; 12():5373-5386. PubMed ID: 28794629
[TBL] [Abstract][Full Text] [Related]
16. Design of a novel theranostic nanomedicine: synthesis and physicochemical properties of a biocompatible polyphosphazene-platinum(II) conjugate.
Avaji PG; Park JH; Lee HJ; Jun YJ; Park KS; Lee KE; Choi SJ; Lee HJ; Sohn YS
Int J Nanomedicine; 2016; 11():837-51. PubMed ID: 27042052
[TBL] [Abstract][Full Text] [Related]
17. Selective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugates.
Jun YJ; Kim JI; Jun MJ; Sohn YS
J Inorg Biochem; 2005 Aug; 99(8):1593-601. PubMed ID: 15963570
[TBL] [Abstract][Full Text] [Related]
18. Polymer-drug conjugates: recent development in clinical oncology.
Li C; Wallace S
Adv Drug Deliv Rev; 2008 May; 60(8):886-98. PubMed ID: 18374448
[TBL] [Abstract][Full Text] [Related]
19. Polymer-drug conjugates: current status and future trends.
Greco F; Vicent MJ
Front Biosci; 2008 Jan; 13():2744-56. PubMed ID: 17981750
[TBL] [Abstract][Full Text] [Related]
20. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
